Community-acquired pneumonia in children: What's old? What's new?

Acta Paediatrica, International Journal of Paediatrics

Volumn 99, Issue 11, 2010, Pages 1602-1608

  Don, Massimiliano ^a   Canciani, Mario ^a   Korppi, Matti ^b  

^a UNIVERSITY OF UDINE   (Italy)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Amoxicillin; Community acquired pneumonia; Human bocavirus; Human metapneumovirus; Macrolide; Pleural effusion; Simkania negevensis

Indexed keywords

AMOXICILLIN; MACROLIDE; PENICILLIN G;

BACTERIUM; BOCAVIRUS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; DRUG EFFICACY; EMPYEMA; HUMAN; METAPNEUMOVIRUS; MORBIDITY; MYCOPLASMA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; RHINOVIRUS; SIMKANIA NEGEVENSIS; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

CHILD; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; PNEUMONIA; TREATMENT OUTCOME; WORLD HEALTH;

EID: 78649666919     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2010.01924.x     Document Type: Review

References (60)

1. British Thoracic Society Standards of Care Committee. BTS Guidelines for the Management of Community Acquired Pneumonia in Childhood. Thorax 2002; 57 (Suppl. 1): I1-23.
2. Korppi M. Community-acquired pneumonia in children: Issues in optimizing antibacterial treatment. Paediatr Drugs 2003; 5: 821-32.
3. Juven T, Mertsola J, Waris M, Leinonen M, Meurman O, Roivainen M, et al. Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J 2000; 19: 293-8.
4. Michelow IC, Olsen K, Lozano J, Rollins NK, Duffy LB, Ziegler T, et al. Epidemiology and clinical characteristics of community- acquired pneumonia in hospitalized children. Pediatrics 2004; 113: 701-7.
5. Senstad AC, Suren P, Brauteset L, Eriksson JR, Hoiby EA, Wathne K-O. Community cquired pneumonia (CAP) in children in Oslo, Norway. Acta Paediatr 2009; 98: 332-6.
6. Hazir T, Nisar YB, Qazi SA, Khan SF, Raza M, Zameer S, et al. Chest radiography in children aged 2-59 months diagnosed with non-severe pneumonia as defined by World Health Organization: Descriptive multicentre study in Pakistan. Br Med J 2006; 333: 629-33.
7. Korppi M. Mixed microbial aetiology of community-acquired pneumonia in children. APMIS 2002; 110: 515-22.
8. Don M, Fasoli L, Paldanius M, Vainionpaa R, Kleemola M, Raty R, et al. Aetiology of community-acquired pneumonia: Serological results of a paediatric survey. Scand J Infect Dis 2005; 37: 806-12.
9. Principi N, Esposito S, Blasi F, Allegra L. Role of Mycoplasma pneumoniae and Chlamydophila pneumoniae in children with community-acquired lower respiratory tract infections. Clin Infect Dis 2001; 32: 1281-9. (Pubitemid 32405899)
10. Michelow IC, Lozano J, Olsen K, Goto C, Rollins NK, Ghaffar F, et al. Diagnosis of Streptococcus pneumoniae lower respiratory infection in hospitalized children by culture, polymerase chain reaction, serological testing, and urinary antigen detection. Clin Infect Dis 2002; 34: E1-11.
11. Korppi M, Heiskanen-Kosma T, Kleemola M. Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: Serological results of a prospective, population- based study in primary health care. Respirology 2004; 9: 109-14.
12. van den Hoogen BG, de Jong JC, Groen J, Kuiken T, de Groot R, Fouchier RA, et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 2001; 7: 719-24.
13. Crowe JE. Human metapneumovirus as a major cause of human respiratory tract disease. Pediatr Infect Dis J 2004; 23: S215-21.
14. van den Hoogen BG, Osterhaus DM, Fouchier RA. Clinical impact and diagnosis of human metapneumovirus infection. Pediatr Infect Dis J 2004; 23: S25-32.
15. van den Hoogen BG, van Doornum GJ, Fockens JC, Cornelissen JJ, Beyer WE, de Groot R, et al. Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients. J Infect Dis 2003; 188: 1571-7.
16. Leung J, Esper F, Weibel C, Kahn JS. Seroepidemiology of human metapneumovirus (hMPV) on the basis of a novel enzyme-linked immunosorbent assay utilizing hMPV fusion protein expressed in recombinant vesicular stomatitis virus. J Clin Microbiol 2005; 43: 1213-9.
17. Williams JV, Harris PA, Tollefson SJ, Halburnt-Rush LL, Pingsterhaus JM, Edwards KM, et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med 2004; 350: 443-50.
18. Madhi SA, Ludewick H, Abed Y, Klugman KP, Boivin G. Human metapneumovirus-associated lower respiratory tract infections among hospitalized human immunodeficiency virus type 1 (HIV-1)-infected and HIV-1-uninfected African infants. Clin Infect Dis 2003; 37: 1705-10.
19. Peiris JS, Tang WH, Chan KH, Khong PL, Guan Y, Lau YL, et al. Children with respiratory disease associated with metapneumovirus in Hong Kong. Emerg Infect Dis 2003; 9: 628-33.
20. Boivin G, De Serres G, Côté S, Gilca R, Abed Y, Rochette L, et al. Human metapneumovirus infections in hospitalized children. Emerg Infect Dis 2003; 9: 634-40.
21. Mullins JA, Erdman DD, Weinberg GA, Edwards K, Hall CB, Walker FJ, et al. Human metapneumovirus infection among children hospitalized with acute respiratory illness. Emerg Infect Dis 2004; 10: 700-5. (Pubitemid 38420304)
22. König W, Arnold R, Werchau H, Ihorst G, Forster J, König B. Prospective study of human metapneumovirus infection in children less than 3 years of age. J Clin Microbiol 2004; 42: 4632-5.
23. Choi EH, Lee HJ, Kim SJ, Eun BW, Kim NH, Lee JA, et al. The association of newly identified respiratory viruses with lower respiratory tract infections in Korean children, 2000-2005. Clin Infect Dis 2006; 43: 585-92.
24. Lin PY, Lin TY, Huang YC, Tsao KC, Huang YL. Human metapneumovirus and community-acquired pneumonia in children. Chang Gung Med J 2005; 28: 683-8.
25. Don M, Korppi M, Valent F, Vainionpaa R, Canciani M. Human metapneumovirus pneumonia in children: Results of an Italian study and mini-review. Scand J Infect Dis 2008; 40: 821-6.
26. Wolf DG, Greenberg D, Shemer-Avni Y, Givon-Lavi N, Bar-Ziv J, Dagan R. Association of human metapneumovirus with radiologically diagnosed community-acquired alveolar pneumonia in young children. J Pediatr 2010; 156: 115-20.
27. Allander T, Tammi MT, Eriksson M, Bjerkner A, Tiveljung-Lindell A, Andersson B. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci USA 2005; 102: 12891-6.
28. Kahn JS, Kesebir D, Cotmore SF, D'Abramo A Jr, Cosby C, Weibel C, et al. Seroepidemiology of human bocavirus defined using recombinant virus-like particles. J Infect Dis 2008; 198: 41-50.
29. Allander T, Jartti T, Gupta S, Niesters HG, Lehtinen P, Osterback R, et al. Human bocavirus and acute wheezing in children. Clin Infect Dis 2007; 44: 904-10.
30. Söderlund-Venermo M, Lahtinen A, Jartti T, Hedman L, Kemppainen K, Lehtinen P, et al. Human bocavirus infection in children with acute wheezing: Comparison of serology and PCR in diagnosis and analysis of the clinical profile. Emerg Infect Dis 2009; 15: 1423-30.
31. Zhang LL, Tang LY, Xie ZD, Tan XJ, Li CS, Cui AL, et al. Human bocavirus in children suffering from acute lower respiratory tract infection in Beijing Children's Hospital. Chin Med J (Engl) 2008; 121: 1607-10.
32. Christensen A, Nordbø SA, Krokstad S, Rognlien AG, Døllner H. Human bocavirus commonly involved in multiple viral airway infections. J Clin Virol 2008; 41: 34-7.
33. Völz S, Schildgen O, Klinkenberg D, Ditt V, Müller A, Tillmann RL, et al. Prospective study of Human Bocavirus (HBoV) infection in a pediatric university hospital in Germany 2005 / 2006. J Clin Virol 2007; 40: 229-35.
34. Fry AM, Lu X, Chittaganpitch M, Peret T, Fisher J, Dowell SF, et al. Human bocavirus: A novel parvovirus epidemiologically associated with pneumonia requiring hospitalization in Thailand. J Infect Dis 2007; 195: 1038-45.
35. Cilla G, Oñate E, Perez-Yarza EG, Montes M, Vicente D, Perez-Trallero E. Viruses in community-acquired pneumonia in children aged less than 3 years old: High rate of viral coinfection. J Med Virol 2008; 80: 1843-9.
36. Don M, Soderlund-Venermo M, Valent F, Lahtinen A, Hedman L, CancianiM, et al. Serologically verified human bocavirus pneumonia in children. Pediatr Pulmonol 2010; 45: 120-6.
37. Friedman MG, Dvoskin B, Kahane S. Infections with the Chlamydophila-like microrganism Simkania negevensis, a possible emerging pathogen. Microb Infect 2003; 5: 1013-21.
38. Kumar S, Kahlhoff SA, Gelling M, et al. Infection with Simkania negevensis in Brooklin, New York. Pediatr Infect Dis J 2005; 24: 989-92.
39. Heiskanen-Kosma T, Paldanius M, Korppi M. Simkania negevensis may be a true cause of community acquired pneumonia in children. Scand J Infect Dis 2008; 40: 127-30.
40. Fasoli L, PaldaniusM, Don M, Valent F, Vetrugno L, Korppi M, et al. Simkania negevensis in community-acquired pneumonia in Italian children. Scand J Infect Dis 2008; 40: 269-72.
41. Nascimento-Carvalho CM, Cardoso MR, Paldanius M, Barral A, Araújo-Neto CA, Saukkoriipi A, et al. Simkania negevensis infection among Brazilian children hospitalized with community- acquired pneumonia. J Infect 2009; 58: 250-3.
42. Palafox M, Guiscafré H, Reyes H, Munoz O, Martínez H. Diagnostic value of tachypnoea in pneumonia defined radiologically. Arch Dis Child 2000; 82: 41-5.
43. Hazir T, Qazi SA, Nisar YB, Maqbool S, Asghar R, Iqbal I, et al. Can WHO therapy failure criteria for non-severe pneumonia be improved in children aged 2-59 months? Int J Tuberc Lung Dis 2006; 10: 924-31.
44. Esposito S, Bosis S, Cavagna R, Faelli N, Begliatti E, Marchisio P, et al. Characteristics of Streptococcus pneumoniae and atypical bacterial infections in children 2-5 years of age with community- acquired pneumonia. Clin Infect Dis 2002; 35: 1345-52.
45. Juven T, Ruuskanen O, Mertsola J. Symptoms and signs of community-acquired pneumonia in children. Scand J Prim Health Care 2003; 21: 52-6.
46. Korppi M, Don M, Valent F, Canciani M. The value of clinical features in differentiating between viral, pneumococcal and atypical bacterial pneumonia in children. Acta Paediatr 2008; 97: 943-7.
47. Heiskanen-Kosma T, Korppi M. Serum C-reactive protein cannot differentiate bacterial and viral aetiology of communityacquired pneumonia in children in primary health care settings. Scand J Infect Dis 2000; 32: 399-402.
48. Korppi M, Remes S, Heiskanen-Kosma T. Serum procalcitonin concentrations in bacterial pneumonia in children: A negative result in primary health care settings. Pediatr Pulmonol 2003; 35: 56-61.
49. Don M, Valent F, Korppi M, Falleti E, De Candia A, Fasoli L, et al. Efficacy of serum procalcitonin in evaluating severity of community-acquired pneumonia in childhood. Scand J Infect Dis 2007; 39: 129-37.
50. Korppi M, Remes S. Serum procalcitonin in pneumococcal pneumonia in children. Eur Respir J 2001; 17: 623-7.
51. Toikka P, Irjala K, Juvén T, Virkki R, Mertsola J, Leinonen M, et al. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J 2000; 19: 598-602.
52. Virkki R, Juten T, Rikalainen K, Svedström E, Mertsola J, Ruuskanen O. Differentiation of bacterial and viral pneumonia in children. Thorax 2002; 57: 438-41.
53. Kabra SK, Lodha R, Pandey RM. Antibiotics for communityacquired pneumonia in children. Cochrane Database Syst Rev 2010; 3: CD004874.
54. Rojas MX, Granados C. Oral antibiotics versus parenteral antibiotics for severe pneumonia in children. Cochrane Database Syst Rev 2006; 2: CD00497.
55. Atkinson M, Lakhanpaul M, Smyth A, Vyas H, Weston V, Sithole J, et al. Comparison of oral amoxicillin and intravenous benzyl penicillin for community acquired pneumonia in children (PIVOT trial): A multicentre pragmatic randomised controlled equivalence trial. Thorax 2007; 62: 1102-6.
56. Hazir T, Qazi SA, Nisar YB, Maqbool S, Asghar R, Iqbal I, et al. Comparison of standard versus double dose of amoxicillin in the treatment of non-severe pneumonia in children aged 2-59 months: A multi-centre, double blind, randomised controlled trial in Pakistan. Arch Dis Child 2007; 92: 291-7.
57. Agarwal G, Awasthi S, Kabra SK, Kaul A, Singhi S, Walter SD; ISCAP Study Group. Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: A multicentre randomised controlled trial. BMJ 2004; 328: 791-4.
58. Haider BA, Saeed MA, Bhutta ZA. Short-course versus longcourse antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months. Cochrane Database Syst Rev 2008; 2: CD005976.
59. Clements H, Stephenson T, Gabriel V, Harrison T, Millar M, Smyth A, et al. Rationalised prescribing for community acquired pneumonia: A closed loop audit. Arch Dis Child 2000; 83: 320-4.
60. Virkki R, Juven T, Mertsola J, Ruuskanen O. Radiographic follow- up of pneumonia in children. Pediatr Pulmonol 2005; 40: 223-7.